CLPT
ClearPoint Neuro, Inc.
Medical Devices · Healthcare · United States
10.67
close · 2026-10-30
value
36
cheaper than peers36
quality
8
stronger fundamentals8
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 2 years ago | -4.3% | 55 |
| earnings yield, 1 year ago | -6.6% | 54 |
| earnings yield, 3 years ago | -6.4% | 54 |
| cash flow yield, 1 year ago | -2.7% | 54 |
| earnings yield, 2 years ago | -8.4% | 53 |
| earnings yield, latest year | -8.4% | 51 |
| cash flow yield, 3 years ago | -5.1% | 49 |
| cash flow yield, latest year | -7.1% | 40 |
| price to sales | 8.09× | 14 |
| price to book | 12.54× | 10 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 18.1% | 71 |
| operating margin | -94.2% | 15 |
| return on equity | -226.5% | 10 |
| debt to equity | 593.4% | 3 |
4 of 4 measures available
Facts
| market cap | $342M |
| free cash flow | -$14.1M |
| employees | 160 |
| first trade | 2012-05-22 |
| next earnings | 2026-10-28 |
| fundamentals updated | 2026-10-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.90 | -0.70 | -0.90 | -0.68 |
| free cash flow | -$24.4M | -$9.2M | -$14.8M | -$17.3M |
| net income | -$25.5M | -$18.9M | -$22.1M | -$16.4M |
| revenue | $37.0M | $31.4M | $24.0M | $20.6M |